Galanin is a Selective Marker of the Retrotrapezoid Nucleus in Rats
Overview
Authors
Affiliations
The rat retrotrapezoid nucleus (RTN) contains CO(2)-activated neurons that contribute to the central chemoreflex and to breathing automaticity. These neurons have two known markers, the transcription factor Phox2b and vesicular glutamate transporter 2 (VGLUT2). Noncatecholaminergic galanin-immunoreactive (ir) neurons within a region of the lower brainstem that seems identical to what is currently defined as the RTN have been previously described. Here we ask whether these galanin-expressing neurons are the same cells as the recently characterized CO(2)-sensitive neurons of the RTN. By using in situ hybridization, we found that pre-pro-galanin (PPGal) mRNA is expressed by an isolated cluster of neurons that is co-extensive with the RTN as defined by a population of strongly Phox2b-ir neurons devoid of tyrosine hydroxylase (Phox2b(+)/TH(-) neurons). This bilateral structure contains about 1,000 PPGal mRNA-positive neurons in the rat. The PPGal mRNA-positive neurons were Phox2b(+)/TH(-) and as susceptible to destruction by the toxin [Sar(9), Met (O(2))(11)]-substance P as the rest of the RTN Phox2b(+)/TH(-) cells of the RTN. CO(2)-activated neurons were recorded in the RTN of anesthetized rats and were labeled with biotinamide. Many of those cells (7/17, 41%, five rats) contained PPGal-mRNA. In conclusion, galanin mRNA is a very specific marker of the glutamatergic Phox2b(+)/TH(-) neurons of the RTN, but galanin mRNA identifies only half of these putative central respiratory chemoreceptors.
Souza G, Abbott S Respir Physiol Neurobiol. 2024; 322:104217.
PMID: 38237884 PMC: 10922619. DOI: 10.1016/j.resp.2024.104217.
Gonye E, Bayliss D Front Physiol. 2023; 14:1241662.
PMID: 37719465 PMC: 10502317. DOI: 10.3389/fphys.2023.1241662.
Grams K, Neumueller S, Mouradian Jr G, Burgraff N, Hodges M, Pan L Physiol Genomics. 2023; 55(11):487-503.
PMID: 37602394 PMC: 11178267. DOI: 10.1152/physiolgenomics.00038.2023.
Souza G, Stornetta D, Shi Y, Lim E, Berry F, Bayliss D J Neurosci. 2023; 43(30):5501-5520.
PMID: 37290937 PMC: 10376939. DOI: 10.1523/JNEUROSCI.0386-23.2023.
Kurogochi K, Uechi M, Orito K Front Pharmacol. 2022; 13:1020685.
PMID: 36339556 PMC: 9627219. DOI: 10.3389/fphar.2022.1020685.